Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review

World Journal of Pediatrics

Volumn 11, Issue 4, 2015, Pages 293-299

  Olusanya, Bolajoko O ^a,b   Slusher, Tina M ^a,c  

^a Center for Healthy Start Initiative 286A Corporation Drive ^*  (Nigeria)

^b Healthy Start Initiative   (Nigeria)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

bilirubin encephalopathy; developing countries; kernicterus; perinatal outcomes; risk factors

Indexed keywords

GLUCURONOSYLTRANSFERASE; PYRUVATE KINASE;

ADOLESCENT PREGNANCY; BANGLADESH; BENIN; BIRTH INJURY; BLOOD GROUP ABO INCOMPATIBILITY; BOLIVIA; BREAST FEEDING; CONGO; COTE D'IVOIRE; CUBA; DEHYDRATION; DELIVERY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUCED LABOR; EGYPT; ENZYME DEFECT; ENZYME DEFICIENCY; ERYTHROCYTE DISORDER; ETHNICITY; FOLIC ACID DEFICIENCY; GALACTOSEMIA; GENDER; GENETIC POLYMORPHISM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEREDITY; HUMAN; HYPOGLYCEMIA; HYPOTHERMIA; INDIA; INFANT; IRAQ; JORDAN; KENYA; LABOR; LIVE BIRTH; LOW BIRTH WEIGHT; MORBIDITY; MOZAMBIQUE; MYANMAR; NEONATAL HYPERBILIRUBINEMIA; NEPAL; NEWBORN INFECTION; NEWBORN JAUNDICE; NIGERIA; PAKISTAN; PALESTINE; PAPUA NEW GUINEA; PERINATAL ASPHYXIA; POLYCYTHEMIA; PREMATURITY; PRIMIPARA; PYRUVATE KINASE DEFICIENCY; REVIEW; RHESUS INCOMPATIBILITY; RISK FACTOR; SRI LANKA; SUDAN; SYSTEMATIC REVIEW; VANUATU; WEIGHT REDUCTION; YEMEN; ZIMBABWE; DEVELOPING COUNTRY; HYPERBILIRUBINEMIA, NEONATAL; NEWBORN; SOCIOECONOMICS;

DEVELOPING COUNTRIES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84943641023     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-015-0037-z     Document Type: Review

References (28)

1. Stevenson DK, Dennery PA, Hintz SR. Understanding newborn jaundice. J Perinatol 2001;21 Suppl 1:S21–S24; discussion S35-S39.
2. National Institute for Health and Clinical Excellence. Neonatal jaundice (Clinical guideline 98). 2010. www.nice.org.uk/CG98 (accessed September 3, 2014).
3. Lazarus C, Avchen RN. Neonatal hyperbilirubinemia management: a model for change. J Perinatol 2009;29 Suppl 1:S58–S60.
4. Olusanya BO, Ogunlesi TA, Slusher TM. Why is kernicterus still a major cause of death and disability in low-income and middleincome countries? Arch Dis Child 2014;99:1117–1121.
5. Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114:e130–e153.
6. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013;74 Suppl 1:86–100.
7. Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every Newborn: progress, priorities, and potential beyond survival. Lancet 2014;384:189–205.
8. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific allcause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–171.
9. Olusanya BO. State of the world’s children: life beyond survival. Arch Dis Child 2005;90:317–318.
10. Blencowe H, Vos T, Lee AC, Philips R, Lozano R, Alvarado MR, et al. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. Pediatr Res 2013;74 Suppl 1:4–16.
11. Shiffman J. Issue attention in global health: the case of newborn survival. Lancet 2010;375:2045–2049.
12. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy 2005;10 Suppl 1:35–48.
13. Mwaniki MK, Atieno M, Lawn JE, Newton CR. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012;379:445–452.
14. Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE 2015;10:e0117229.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
16. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
17. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Psychiatry Res Methodol 2005;8:19–32.
18. Colquhoun HL, Levac D, O’Brien KK, Straus S, Tricco AC, Perrier L, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol 2014;67:1291–1294.
19. Gough D, Thomas J, Oliver S. Clarifying differences between review designs and methods. Syst Rev 2012;1:28.
20. Seale AC, Blencowe H, Zaidi A, Ganatra H, Syed S, Engmann C, et al. Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010. Pediatr Res 2013;74 Suppl 1:73–85.
21. Watchko JF, Jeffrey Maisels M. Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal Neonatal Med 2010;15:136–140.
22. Blencowe H, Lee AC, Cousens S, Bahalim A, Narwal R, Zhong N, et al. Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr Res 2013;74 Suppl 1:17–34.
23. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD defi ciency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical modelbased map. PLoS Med 2012;9:e1001339.
24. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase defi ciency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009;42:267–278.
25. Olusanya BO, Emokpae AA, Zamora TG, Slusher TM. Severe neonatal hyperbilirubinaemia in low and middle-income countries with significant G6PD-deficiency. Acta Paediatr 2014;103:1102–1109.
26. Kaplan M, Slusher T, Renbaum P, Essiet DF, Pam S, Levy-Lahad E, et al. (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates. Pediatr Res 2008;63:109–111.
27. Lumbiganon P, Laopaiboon M, Gülmezoglu AM, Souza JP, Taneepanichskul S, Ruyan P, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007–08. Lancet 2010;375:490–499.
28. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006;367:1819–1829.